AstraZeneca’s Trixeo has been approved in the EU as a [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

AstraZeneca’s Trixeo Aerosphere has been recommended for approval in the [...]

The EMA’s CHMP has recommended marketing authorisation for two obicetrapib [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Pierre Fabre Laboratories has received a positive opinion from the [...]

Chiesi Global Rare Diseases has received a positive CHMP opinion [...]

The European Medicines Agency’s Committee for Medicinal Product for Human [...]

AstraZeneca has received a positive recommendation from the Committee for [...]